Nov 23, 2020
1Globe Biomedical today presented their comprehensive global study on Molecular Colorectal Cancer with research spanning 5 years from 2015 to 2020.
Oct 29, 2020
1Globe Biomedical today announced that its scientists are testing materials used in medical implants to analyze the immune response to reduce implant rejection.
Oct 09, 2020
1Globe Biomedical today announced the results of its survey and their analysts forecast that the biological market is likely to reach US$3 billion by 2025.
Oct 06, 2020
1Globe Biomedical of Hong Kong announced today that they will host their Third Quarter financial results conference on in the last week of October.
Oct 01, 2020
1Globe Biomedical today announced the appointment of Dr. Thomas Parker PhD as the company's new Chief Medical Officer effective immediately.
Sep 29, 2020
1Globe Biomedical today announced it is teaming up with a Korean biomedical firm to accelerate the production of T-cell based cancer treatments and tumors.